Life-threatening intracranial bleeding in a newborn with congenital cytomegalovirus infection: Late-onset neonatal hemorrhagic disease

Pediatric Hematology and Oncology

Volumn 28, Issue 1, 2011, Pages 78-82

  Dallar, Yildiz ^a   Tiras, Ulku ^a   Catakli, Tulin ^a   Gulal, Gonul ^a   Sayar, Yavuz ^a   Selvar, Beray ^a   Alioglu, Bulent ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

congenital cytomegalovirus infection; intracranial hemorrhage; late onset hemorrhagic disease of newborn

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMIKACIN; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; CEFTAZIDIME; CYTOMEGALOVIRUS ANTIBODY; FIBRINOGEN; FRESH FROZEN PLASMA; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; HEPATITIS B VACCINE; IMIPENEM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHENOBARBITAL; PROTEIN C; URSODEOXYCHOLIC ACID; VANCOMYCIN; VITAMIN K GROUP; VITRONECTIN;

ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BINDING AFFINITY; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD COMPONENT THERAPY; BREAST MILK; CASE REPORT; CELLULITIS; CHOLESTASIS; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; FEVER; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEMATOMA; HUMAN; HYDROCEPHALUS; INFANT; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER DISEASE; LIVER DYSFUNCTION; MUSCLE BLEEDING; NEUROSURGERY; NEWBORN HEMORRHAGIC DISEASE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETINA HEMORRHAGE; SEROLOGY; SHUNTING; SUBARACHNOID HEMORRHAGE; THROMBIN TIME; TOTAL PARENTERAL NUTRITION; TREATMENT PLANNING; TREATMENT RESPONSE; VITAMIN K DEFICIENCY;

CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; INTRACRANIAL HEMORRHAGES; PROTHROMBIN TIME; VITAMIN K DEFICIENCY BLEEDING;

EID: 79952179438     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2010.513032     Document Type: Article

References (10)

1. Cantor AB. Developmental hemostasis: relevance to newborns and infants. In: Nathan DG, Orkin SH, Ginsburg D, et al., eds. Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. Pennsylvania: WB Saunders; 2009:147-191.
2. Ewald P, Ludwig P. The neonatal coagulation system and the vitamin K deficiency bleeding: mini review. Wien Med Wochenschr. 2008;158:385-395.
3. Loughan PM, McDougall PN. Epidemiology of late onset haemorrhagic disease: a pooled data analysis. J Paediatr Child Health. 1993;29:177-181. (Pubitemid 23160351)
4. Demmler GJ. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis. 1991;13:315-329.
5. Brugnara C. Reference values in infancy and childhood. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, eds. Nathan and Oski's Hematology of Infancy and Childhood. 6th ed. Pennsylvania: WB Saunders; 2003:1835-1864.
6. Ciantelli M, Bartalena L, Bernardini M, et al. Late vitamin K deficiency bleeding after intramusculer prophylaxis at birth: case report. J Perinatol. 2009;29:168-169.
7. American Academy of Pediatrics Committee on Fetus and Newborn. Controversies vitamin K and the newborn. Pediatrics. 2003;112:191-192.
8. Aydinli N, Citak A, Caliskan M, et al. Vitamin K deficiency - late onset intracranial haemorrhage. Eur J Ped Neurol. 1998;2:199-203. (Pubitemid 28445024)
9. Yamada K, Fukao T, Suzuki H, et al. Vitamin K-deficient intracranial hemorrhage as the first symptom of cytomegalovirus hepatitis with cholestasis. Tohoku J Exp Med. 2007;212:335-339. (Pubitemid 47304999)
10. Vancíková Z, Kucerová T, Pelikán L, et al. Perinatal cytomegalovirus hepatitis: to treat or not to treat with ganciclovir. J Paediatr Child Health. 2004;40:444-448. (Pubitemid 39070713)